Novel insights into G protein and G protein-coupled receptor signaling in cancer.

G protein-coupled receptors (GPCRs) play a central role in signal transmission, thereby controlling many facets of cellular function. Overwhelming evidence now implicates GPCRs, G proteins and their downstream signaling targets in cancer initiation and progression, where they can influence aberrant cell growth and survival, largely through activation of AKT/mTOR, MAPKs, and Hippo signaling pathways. GPCRs also play critical roles in the invasion and metastasis of cancer cells via activation of Rho GTPases and cytoskeletal changes, and angiogenesis to supply the tumor with nutrients and provide routes for metastasis. Lastly, GPCRs contribute to the establishment and maintenance of a permissive tumor microenvironment. Understanding GPCR involvement in cancer malignancy may help identify novel therapeutic opportunities for cancer prevention and treatment.

[1]  J. Gutkind,et al.  Human tumor-associated viruses and new insights into the molecular mechanisms of cancer , 2008, Oncogene.

[2]  Ji Luo,et al.  The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism , 2006, Nature Reviews Genetics.

[3]  B. Berk,et al.  Crosstalk coregulation mechanisms of G protein-coupled receptors and receptor tyrosine kinases. , 2006, Methods in molecular biology.

[4]  J. Nathans,et al.  Signaling by sensory receptors. , 2012, Cold Spring Harbor perspectives in biology.

[5]  Lee L. Rubin,et al.  Targeting the Hedgehog pathway in cancer , 2006, Nature Reviews Drug Discovery.

[6]  M. Merino,et al.  Activating mutations of the stimulatory G protein in the McCune-Albright syndrome. , 1991, The New England journal of medicine.

[7]  Rajnish A. Gupta,et al.  Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2 , 2001, Nature Reviews Cancer.

[8]  R. DuBois,et al.  COX-2: a molecular target for colorectal cancer prevention. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  Jonathan W. Pillow,et al.  POSTER PRESENTATION Open Access , 2013 .

[10]  J. Gutkind,et al.  G-protein-coupled receptors and cancer , 2007, Nature Reviews Cancer.

[11]  S. Seshagiri,et al.  The emerging mutational landscape of G proteins and G-protein-coupled receptors in cancer , 2013, Nature Reviews Cancer.

[12]  H. Pan,et al.  Arrestin domain‐containing protein 3 recruits the NEDD4 E3 ligase to mediate ubiquitination of the β2‐adrenergic receptor , 2010, EMBO reports.

[13]  A. Klein-Szanto,et al.  Identification of the Rac-GEF P-Rex1 as an essential mediator of ErbB signaling in breast cancer. , 2010, Molecular cell.

[14]  S. Rasmussen,et al.  The structure and function of G-protein-coupled receptors , 2009, Nature.

[15]  Xiang-Dong Fu,et al.  Regulation of the Hippo-YAP Pathway by G-Protein-Coupled Receptor Signaling , 2012, Cell.

[16]  W. Moolenaar.  G-protein-coupled receptors, phosphoinositide hydrolysis, and cell proliferation. , 1991, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[17]  David J. Forsthoefel,et al.  A genome-wide RNAi screen reveals a Trio-regulated Rho GTPase circuitry transducing mitogenic signals initiated by G protein-coupled receptors. , 2013, Molecular cell.

[18]  T. Katada,et al.  Bacterial toxins as probe for receptor-Gi coupling. , 1990, Advances in second messenger and phosphoprotein research.

[19]  J. Hepler,et al.  Cell signalling diversity of the Gqα family of heterotrimeric G proteins , 2006 .

[20]  T. Kipps,et al.  CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment. , 2006, Blood.

[21]  R. Strieter,et al.  CXC chemokine modulation of angiogenesis: the importance of balance between angiogenic and angiostatic members of the family. , 1998, Journal of investigative medicine : the official publication of the American Federation for Clinical Research.

[22]  P. Friedl,et al.  Tumour-cell invasion and migration: diversity and escape mechanisms , 2003, Nature Reviews Cancer.

[23]  S. Nie,et al.  Inhibition of Breast Cancer Metastasis by Selective Synthetic Polypeptide against CXCR4 , 2004, Cancer Research.

[24]  A. Ullrich,et al.  Receptor tyrosine kinase signalling as a target for cancer intervention strategies. , 2001, Endocrine-related cancer.

[25]  R. McIntyre,et al.  The activating mutation R201C in GNAS promotes intestinal tumourigenesis in ApcMin/+ mice via activation of Wnt and ERK1/2 MAPK pathways , 2010, Oncogene.

[26]  B. Hemmings,et al.  PI3K-PKB/Akt pathway. , 2012, Cold Spring Harbor perspectives in biology.

[27]  P. Bork,et al.  Characterization of the Mammalian YAP (Yes-associated Protein) Gene and Its Role in Defining a Novel Protein Module, the WW Domain (*) , 1995, The Journal of Biological Chemistry.

[28]  Paolo Sassone-Corsi,et al.  The cyclic AMP pathway. , 2012, Cold Spring Harbor perspectives in biology.

[29]  J. Lévesque,et al.  Disruption of the CXCR4/CXCL12 chemotactic interaction during hematopoietic stem cell mobilization induced by GCSF or cyclophosphamide. , 2003, The Journal of clinical investigation.

[30]  R. Abagyan,et al.  Molecular mechanisms deployed by virally encoded G protein-coupled receptors in human diseases. , 2013, Annual review of pharmacology and toxicology.

[31]  N. Prevarskaya,et al.  Calcium in tumour metastasis: new roles for known actors , 2011, Nature Reviews Cancer.

[32]  S. Narumiya,et al.  Acceleration of intestinal polyposis through prostaglandin receptor EP2 in ApcΔ716 knockout mice , 2001, Nature Medicine.

[33]  H. Bourne,et al.  GTPase inhibiting mutations activate the α chain of Gs and stimulate adenylyl cyclase in human pituitary tumours , 1989, Nature.

[34]  Tracy M Handel,et al.  Chemokines and cancer: migration, intracellular signalling and intercellular communication in the microenvironment. , 2008, The Biochemical journal.

[35]  E. Cesarman,et al.  Human herpesvirus KSHV encodes a constitutively active G-protein-coupled receptor linked to cell proliferation , 1997, Nature.

[36]  E. Hirsch,et al.  Phosphoinositide 3‐kinase p110γ in immunity , 2011, IUBMB life.

[37]  M. Zemel,et al.  Prostaglandin E2 Protects Intestinal Tumors from Nonsteroidal Anti-inflammatory Drug-induced Regression in ApcMin/+ Mice , 2002 .

[38]  E. Rozengurt.  Early signals in the mitogenic response. , 1986, Science.

[39]  H. Yagi,et al.  PDZ-RhoGEF and LARG Are Essential for Embryonic Development and Provide a Link between Thrombin and LPA Receptors and Rho Activation* , 2013, The Journal of Biological Chemistry.

[40]  D. Pan,et al.  The hippo signaling pathway in development and cancer. , 2010, Developmental cell.

[41]  B. Rollins,et al.  Inflammatory chemokines in cancer growth and progression. , 2006, European journal of cancer.

[42]  M. Kazanietz,et al.  Protein kinase C and other diacylglycerol effectors in cancer , 2007, Nature Reviews Cancer.

[43]  K. Guan,et al.  The Hippo pathway: regulators and regulations. , 2013, Genes & development.

[44]  Lawrence Lum,et al.  The Hedgehog Response Network: Sensors, Switches, and Routers , 2004, Science.

[45]  L. Luttrell,et al.  Beyond Desensitization: Physiological Relevance of Arrestin-Dependent Signaling , 2010, Pharmacological Reviews.

[46]  R. Gravel,et al.  Identification of G protein α subunit mutations in human growth hormone (GH)- and GH/prolactin-secreting pituitary tumors by single-strand conformation polymorphism (SSCP) analysis , 1992, Molecular and Cellular Endocrinology.

[47]  M. Zemel,et al.  Prostaglandin E(2) protects intestinal tumors from nonsteroidal anti-inflammatory drug-induced regression in Apc(Min/+) mice. , 2002, Cancer research.

[48]  Q. Gu,et al.  Activating Smoothened mutations in sporadic basal-cell carcinoma , 1998, Nature.

[49]  M. Hull,et al.  Prostaglandin EP receptors: targets for treatment and prevention of colorectal cancer? , 2004, Molecular cancer therapeutics.

[50]  G. Velasco,et al.  Towards the use of cannabinoids as antitumour agents , 2012, Nature Reviews Cancer.

[51]  R. Lefkowitz,et al.  Signalling: Seven-transmembrane receptors , 2002, Nature Reviews Molecular Cell Biology.

[52]  R. Neubig,et al.  Structure of Gαq-p63RhoGEF-RhoA Complex Reveals a Pathway for the Activation of RhoA by GPCRs , 2007, Science.

[53]  T. Mcclanahan,et al.  Involvement of chemokine receptors in breast cancer metastasis , 2001, Nature.

[54]  A. C. Magalhães,et al.  Regulation of GPCR activity, trafficking and localization by GPCR‐interacting proteins , 2012, British journal of pharmacology.

[55]  J. Gutkind.  The Pathways Connecting G Protein-coupled Receptors to the Nucleus through Divergent Mitogen-activated Protein Kinase Cascades* , 1998, The Journal of Biological Chemistry.

[56]  Albert Zlotnik,et al.  Homeostatic chemokine receptors and organ-specific metastasis , 2011, Nature Reviews Immunology.

[57]  I. Macdonald,et al.  Metastasis: Dissemination and growth of cancer cells in metastatic sites , 2002, Nature Reviews Cancer.

[58]  D. Sabatini,et al.  mTOR Signaling. , 2012, Cold Spring Harbor perspectives in biology.

[59]  H. Moch,et al.  Chemokine receptor CXCR4 downregulated by von Hippel–Lindau tumour suppressor pVHL , 2003, Nature.

[60]  P. Crespo,et al.  Linkage of G Protein-Coupled Receptors to the MAPK Signaling Pathway Through PI 3-Kinase γ , 1997, Science.

[61]  J M Trent,et al.  KiSS-1, a novel human malignant melanoma metastasis-suppressor gene. , 1996, Journal of the National Cancer Institute.

[62]  K. Druey,et al.  Prostaglandin E2 Promotes Colon Cancer Cell Growth Through a Gs-Axin-ß-Catenin Signaling Axis , 2005, Science.

[63]  J. Pouysségur,et al.  Transmembrane signalling pathways initiating cell growth in fibroblasts. , 1988, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[64]  R. Lefkowitz,et al.  Mitogenic signaling via G protein-coupled receptors. , 1996, Endocrine reviews.

[65]  F. Balkwill.  Cancer and the chemokine network , 2004, Nature Reviews Cancer.

[66]  J. Pouysségur,et al.  Two growth factor signalling pathways in fibroblasts distinguished by pertussis toxin , 1987, Nature.

[67]  Keshava Rajagopal,et al.  Teaching old receptors new tricks: biasing seven-transmembrane receptors , 2010, Nature Reviews Drug Discovery.

[68]  H. Sheng,et al.  Prostaglandin E2 Stimulates the β-Catenin/T Cell Factor-dependent Transcription in Colon Cancer* , 2005, Journal of Biological Chemistry.

[69]  K. Paavola,et al.  Adhesion G Protein-Coupled Receptors: Signaling, Pharmacology, and Mechanisms of Activation , 2012, Molecular Pharmacology.

[70]  A. Ullrich,et al.  EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF , 1999, Nature.

[71]  J. Pouysségur,et al.  Angiogenesis and G-protein-coupled receptors: signals that bridge the gap , 2001, Oncogene.

[72]  R. DuBois,et al.  PROSTAGLANDINS AND CANCER , 2005, Gut.

[73]  P. Hawkins,et al.  P-Rex1, a PtdIns(3,4,5)P3- and Gβγ-Regulated Guanine-Nucleotide Exchange Factor for Rac , 2002, Cell.

[74]  M. Maggiolini,et al.  G protein-coupled receptors: novel targets for drug discovery in cancer , 2010, Nature Reviews Drug Discovery.

[75]  Tieliu Shi,et al.  GPR116, an adhesion G-protein-coupled receptor, promotes breast cancer metastasis via the Gαq-p63RhoGEF-Rho GTPase pathway. , 2013, Cancer research.

[76]  J. Gutkind,et al.  P‐REX2, a novel PI‐3‐kinase sensitive Rac exchange factor , 2004, FEBS letters.

[77]  R. Proia,et al.  The sphingosine 1-phosphate receptor S1P2 maintains germinal center B cell homeostasis and promotes niche confinement , 2011, Nature Immunology.

[78]  A. Howe.  Cross-talk between calcium and protein kinase A in the regulation of cell migration. , 2011, Current opinion in cell biology.

[79]  A. Newton,et al.  Protein kinase C: poised to signal. , 2010, American journal of physiology. Endocrinology and metabolism.

[80]  Michel Bouvier,et al.  A Synthetic Biology Approach Reveals a CXCR4-G13-Rho Signaling Axis Driving Transendothelial Migration of Metastatic Breast Cancer Cells , 2011, Science Signaling.

[81]  P. Moore,et al.  Clonal Integration of a Polyomavirus in Human Merkel Cell Carcinoma , 2008, Science.

[82]  J. Redondo,et al.  Cyclooxygenase-2: a therapeutic target in angiogenesis. , 2003, Trends in molecular medicine.

[83]  P. Musiani,et al.  Phosphoinositide 3-Kinase p110β Activity: Key Role in Metabolism and Mammary Gland Cancer but Not Development , 2008, Science Signaling.

[84]  Jochen K. Lennerz,et al.  A UV-independent pathway to melanoma carcinogenesis in the redhair-fairskin background , 2012, Nature.

[85]  P. Crespo,et al.  The small GTP-binding proteins Rac1 and Cdc42regulate the activity of the JNK/SAPK signaling pathway , 1995, Cell.

[86]  E. Epstein.  Basal cell carcinomas: attack of the hedgehog , 2008, Nature Reviews Cancer.

[87]  R. Lefkowitz,et al.  The role of beta-arrestins in the termination and transduction of G-protein-coupled receptor signals. , 2002, Journal of cell science.

[88]  Jochen K. Lennerz,et al.  An ultraviolet-radiation-independent pathway to melanoma carcinogenesis in the red hair / fair skin background , 2012 .

[89]  Li Li,et al.  The Hippo-YAP pathway in organ size control and tumorigenesis: an updated version. , 2010, Genes & development.

[90]  J. Hepler,et al.  Cell signalling diversity of the Gqalpha family of heterotrimeric G proteins. , 2006, Cellular signalling.

[91]  R. Taussig,et al.  Inhibition of adenylyl cyclase by Gi alpha. , 1993, Science.

[92]  F. Camargo,et al.  The Hippo signaling pathway and stem cell biology. , 2012, Trends in cell biology.

[93]  Kees Jalink,et al.  Lysophosphatidate-induced cell proliferation: Identification and dissection of signaling pathways mediated by G proteins , 1989, Cell.